Alpha -Tocopherol Acetate Dl- Ascorbic Acid Calciu
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
- Alpha -Tocopherol Acetate Dl- Ascorbic Acid Calciu
- DL-α-Tocopherol / Ascorbic Acid / Cholecalciferol / DHA Complex: Nutritional Supplement — No Repurposing Predictions Available
DL-α-Tocopherol / Ascorbic Acid / Cholecalciferol / DHA Complex: Nutritional Supplement — No Repurposing Predictions Available
One-Sentence Summary
This evidence pack describes an 8-component nutritional supplement combination — comprising Vitamin E, Vitamin C, Calcium, Vitamin D3, Doconexent (DHA), Ferrous Fumarate, Folic Acid, and Pyridoxine — consistent with a prenatal multivitamin formulation. The TxGNN model returned no repurposing predictions for this multi-component query, and the combination is currently not registered in Taiwan. With no original indication on record, no predicted indications, and critical data gaps throughout, this candidate cannot advance to repurposing evaluation at this stage.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not on record |
| Predicted New Indication | No predictions generated |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 — model prediction unavailable |
| Taiwan Market Status | ✗ Not marketed (0 registrations) |
| Number of Registrations | 0 |
| Recommended Decision | Hold |
Conclusion and Next Steps
Decision: Hold
Rationale: The TxGNN pipeline could not generate any repurposing predictions for this multi-component query. Without a single active ingredient resolved to a DrugBank ID, the knowledge graph has no node to traverse, making all downstream scoring impossible.
To proceed, the following is needed:
- Decompose the query into individual active ingredients. Each component (e.g., Doconexent / DHA as DB02088, Cholecalciferol as DB00169, Folic Acid as DB00158) should be submitted as a separate TxGNN query. Multi-component strings are not resolvable by the current mapping layer.
- Confirm clinical intent. Identify whether the target indication is pregnancy support, a specific deficiency condition, or another therapeutic area — this determines which component(s) to prioritise.
- Resolve the DrugBank ID. The DrugBank query returned 1 result (
result_count: 1) but no structured data was captured. Retrieve the full DrugBank record to obtain MOA, categories, and approved indications. - Obtain regulatory package insert. No Taiwan registration exists; sourcing a comparable US FDA or EMA-approved product label (e.g., prenatal vitamin NDA) would fill the safety and indication data gaps.
- Re-run the Evidence Pack pipeline after the above steps to generate a complete candidate report.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.